1. Home
  2. WST vs SNA Comparison

WST vs SNA Comparison

Compare WST & SNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • SNA
  • Stock Information
  • Founded
  • WST 1923
  • SNA 1920
  • Country
  • WST United States
  • SNA United States
  • Employees
  • WST N/A
  • SNA N/A
  • Industry
  • WST Medical/Dental Instruments
  • SNA Industrial Machinery/Components
  • Sector
  • WST Health Care
  • SNA Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • SNA Nasdaq
  • Market Cap
  • WST 18.9B
  • SNA 16.3B
  • IPO Year
  • WST N/A
  • SNA N/A
  • Fundamental
  • Price
  • WST $246.18
  • SNA $326.09
  • Analyst Decision
  • WST Buy
  • SNA Buy
  • Analyst Count
  • WST 7
  • SNA 6
  • Target Price
  • WST $332.50
  • SNA $356.17
  • AVG Volume (30 Days)
  • WST 841.4K
  • SNA 283.2K
  • Earning Date
  • WST 07-24-2025
  • SNA 07-17-2025
  • Dividend Yield
  • WST 0.36%
  • SNA 2.63%
  • EPS Growth
  • WST N/A
  • SNA N/A
  • EPS
  • WST 6.68
  • SNA 18.77
  • Revenue
  • WST $2,960,200,000.00
  • SNA $5,070,900,000.00
  • Revenue This Year
  • WST $5.70
  • SNA N/A
  • Revenue Next Year
  • WST $6.05
  • SNA $3.37
  • P/E Ratio
  • WST $36.83
  • SNA $17.37
  • Revenue Growth
  • WST 2.90
  • SNA N/A
  • 52 Week Low
  • WST $187.43
  • SNA $268.90
  • 52 Week High
  • WST $352.33
  • SNA $373.90
  • Technical
  • Relative Strength Index (RSI)
  • WST 57.91
  • SNA 53.01
  • Support Level
  • WST $237.18
  • SNA $319.62
  • Resistance Level
  • WST $244.36
  • SNA $334.00
  • Average True Range (ATR)
  • WST 5.82
  • SNA 5.29
  • MACD
  • WST -0.41
  • SNA 0.16
  • Stochastic Oscillator
  • WST 51.10
  • SNA 62.72

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About SNA Snap-On Incorporated

Snap-on manufactures premium tools and software for repair professionals. Hand tools are sold through a franchisee-operated mobile van network that serve auto technicians who purchase tools at their own expense. A unique element of its business model is that franchisees bear significant risk, as they must invest in the mobile van, inventory, and software. At the same time, franchisees extend personal credit directly to technicians on an individual tool basis. Snap-on currently operates three segments: repair systems and information, commercial and industrial, and tools. Its finance arm provides financing to franchisees to run their operations, which includes offering loans and leases for mobile vans.

Share on Social Networks: